Lansoprazolo

Lansox, Limpidex, Ermes e altri

Bibliografia - Quali fonti bibliografiche per Lansoprazolo?

1. Agenzia Italiana del Farmaco – AIFA, Lansox – Riassunto Caratteristiche di Prodotto, 2022, 2 luglio https://farmaci.agenziafarmaco.gov.it.


2. Andersson T. et al., Br. J. Clin. Pharmacol., 1998, 45 (4), 369.


3. Ashfaq M. et al., Endocr. Regul., 2022, 56 (2), 134.


4. Barradell L.B. et al., Drugs, 1992, 44(2), 225.


5. Battiston L. et al., Pharmacol. Toxicol., 1997, 81 (6), 247.


6. Bong J.L. et al., BMJ, 2000, 320, 283.


7. Campbell D.R.et al., Am. J. Gastroenterol., 1995, 90 (9), 1577 (abstract).


8. Carvajal A. et al., Drug Saf., 2007, 30 (6), 527.


9. Cavanaugh J. et al., Am. J. Gastroenterol., 1995, 90, 1577 (abstract).


10. Claessens A.A. et al., Pharmacoepidemiol. Drug Saf., 2000, 9 (5), 383.


11. Crauwels H. et al., AIDS Rev., 2013, 15 (2), 87.


12. Diav-Citrin O. et al., Aliment. Pharmacol. Ther., 2005, 21, 269.


13. Food and Drug Administration – FDA, Prevacid – Prescribing Information, 2022 https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020406s094,021428s041lbl.pdf.


14. Frelinger A.L. et al., J. Am. Coll. Cardiol., 2012, 59 (14), 1304.


15. Fuchs W. et al., Br. J. Clin. Pharmacol., 1994, 38 (4), 376.


16. Gerloff J. et al., Acta Pharmacl., 1993, 347, A124.


17. Gerloff J. et al., Eur. J. Clin. Pharmacol., 1996, 50 (4), 293.


18. Granneman G.R. et al., Rher. Drug Monit., 1995, 17 (5), 460.


19. Hamada Y. et al., Pharmacology, 2018, 101 (3-4), 176.


20. Hata M. et al., Thorac. Cardiovasc. Sung.,2015, 63 (1), 45.


21. Hawkey C.J., Gastroenterology, 1991, 100, A80 (abstract).


22. He B. et al., Pharmacotherapy, 2019, 39 (5), 614.


23. Heyman M.B. et al., J. Pedr. Gastroenterol. Nutr., 2007, 44 (1), 35.


24. Hirschowitz B.I. et al., Aliment. Pharmacol. Ther., 1996, 10, 507.


25. Joyce E.et al., BMJ Case Rep., 2021, 14 (5), e240273


26. Juurlink D.N. et al., CMAJ, 2008, 180 (7), 713.


27. Karol M.D. et al., J. Clin. Pharmacol., 1995, 35 (8), 815.


28. Karol M.D. et al., Clin. Pharmacol. Ther., 1997, 61 (4), 450.


29. Karol M.D. et al., J. Clin. Pharmacol., 1999, 39 (12), 1283.


30. Khoshoo V., Dhume P., J. Pediatr. Gastroenterol. Nutr., 2008, 46 (3), 352.


31. Kovacs T.O. et al., Dig. Dis. Sci., 2009, 54 (8), 1693.


32. Kuo C.H. et al., World J. Gastroenterol., 2014, 20 (43), 16029.


33. LactMed, 2022, 15 May https://www.ncbi.nlm.nih.gov/books/NBK501282/ (accesso maggio 2023).


34. Lai K.C. et al., NEJM, 2002, 346 (26), 2033.


35. Landes B.D. et al., Clin. Pharmacokinet., 1995, 28 (6), 458,


36. Langtry H.D., Wilde M.I., Drugs, 1997, 54 (3), 473.


37. Lanza F. et al., 10th World Congress on Gastroenterology, 1994, Abstracs II, 27P.


38. Lefebvre R.A. et al., Clin. Pharmacol. Ther., 1992, 52 (5), 458.


39. Lopez J.L., Tayek J.A., Drug Metab. Dispos., 2016, 44 (1), 124.


40. Lorberbaum T. et al., J. Am. Coll. Cardiol., 2016, 68 (16), 1756.


41. Mainz D. et al., 20th International Congress of Chemotherapy, 1997, giugno-luglio, Sydney.


42. Martin R.M. et al., Br. J. Clin. Pharmacol., 2000, 50, 366.


43. Michel P. et al., Gastroenterol. Clin. Biol., 1994, 18, 1102.


44. Mignon M. et al., Gastroenterol. Clin. Biol., 1994, 18, 13.


45. Miura M. et al., Biopharm. Drug Dispos., 2007, 28 (4), 167.


46. Moffett B.S. et al., Pediatr. Blood Cancer, 2012, 58 (6), 941.


47. Mukherjee S., J. Gastroenterol. Hepatol., 2003, 18, 602 (abstract).


48. Nagata K. et al., Antimicrob. Agents Chemother., 1993, 37, 769.


49. Narumi K. et al., Biopharm. Drug Dispos., 2017, 38 (9), 501.


50. Natsch S. et al., Ann. Pharmacother., 2000, 34, 474.


51. Nishioka S. et al., Rinsho Iyaku, 1996, 12 (13), 2927.


52. Orenstein S.R. et al., J. Pediatr., 2009, 154 (4), 514.


53. Ortiz R.A. et al., Braz. J. Med. Biol. Res., 2007, 40 (3), 383.


54. Pauli-Magnus C. et al., Naunyn Schmiedebergs Arch Pharmacol. 2001, 364(6), 551.


55. Portolés A. et al., J. Clin. Pharmacol., 2006, 46 (10), 1195.


56. Saberi P. et al., Pharmacotherapy, 2011, 31 (3), 253.


57. Santucci R. et al., Anticancer Res., 2010, 30 (9), 3807.


58. Schwab M. et al., Clin. Pharmacol. Ther., 2004, 76 (3), 201.


59. Sekiguchi T. et al., Ther. Res., 1991, 12 (1), 191.


60. Shin J.M., Kim N., J. Neurogastroenterol. Motil., 2013, 19 (1), 25.


61. Small D.S. et al., J. Clin. Pharmacol., 2008, 48 (4), 475.


62. Sontag S.J. et al., Am. J. Gastroenterol., 1997, 92 (3), 429.


63. Sontag S.J. et al., Aliment Pharmacol. Ther., 1997, 11, 147.


64. St Peter J.V.et al., Am. J. Ther., 1995, 2(8), 561.


65. Suzuki K. et al., Br. J. Clin. Pharmacol., 2009, 67 (1), 44.


66. Swarbrick E.T. et al., Eur. J. Gastroenterol. Hepatol., 1996, 8, 431.


67. Tanaka M., Drugs of Today, 1993, 29 (2), 123.


68. Tomilo D.L. et al., Pharmacotherapy, 2006, 26 (3), 341.


69. Umeda N. et al., J. Clin. Gastroenterol., 1995, 20 Suppl. 1, S17.


70. Vakily M. et al., J. Clin. Pharmacol., 2005, 45 (10), 1179.


71. VigiAccess, 2023, maggio https://www.vigiaccess.org/#/ (accesso: maggio 2023).


72. Yamamoto I. et al., J. Clin. Gastroenterol., 1995, 20 Suppl. 1, S38.


73. Yasui-Furukori N. et al., J. Clin. Pharmacol., 2004, 44 (11), 1223.


74. Wormsley K.G. et al., 1992, 33 (Suppl. 1), 548 (abstract).


75. Zhang W. Et al., Paediatr. Drugs, 2008, 10 (4), 265.


76. Ziabek J.A., Anderson C.G., Ann. Pharmacother., 2002, 36, 809.